BioMerieux Research and Development Expenses 2017-2023 | BMXMF
- BioMerieux research and development expenses for the quarter ending December 31, 2023 were $M, a NAN% increase year-over-year.
- BioMerieux research and development expenses for the twelve months ending December 31, 2023 were $0M, a NAN% increase year-over-year.
- BioMerieux annual research and development expenses for 2023 were $0.498B, a 5.83% increase from 2022.
- BioMerieux annual research and development expenses for 2022 were $0.471B, a 2.24% increase from 2021.
- BioMerieux annual research and development expenses for 2021 were $0.46B, a 1.03% increase from 2020.
BioMerieux Annual Research and Development Expenses (Millions of US $) |
|
---|---|
2023 | $498 |
2022 | $471 |
2021 | $460 |
2020 | $456 |
2019 | $419 |
2018 | $386 |
2017 | $344 |
2016 | $301 |
2015 | $ |
BioMerieux Quarterly Research and Development Expenses (Millions of US $) |
|
---|---|
2023-12-31 | |
2023-06-30 | |
2022-12-31 | |
2022-06-30 | |
2021-12-31 | |
2021-06-30 | |
2020-12-31 | |
2019-12-31 | |
2019-06-30 | |
2018-12-31 | |
2018-06-30 | |
2017-12-31 | |
2017-06-30 | |
2016-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $12.894B | $3.977B |
bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $95.766B | 11.88 |
Cencora (COR) | United States | $49.023B | 18.08 |
DiDi Global (DIDIY) | China | $23.330B | 0.00 |
ICON (ICLR) | Ireland | $17.511B | 15.60 |
Natera (NTRA) | United States | $16.712B | 0.00 |
Viatris (VTRS) | United States | $15.433B | 4.75 |
Avantor (AVTR) | United States | $14.831B | 22.24 |
Revvity (RVTY) | United States | $14.647B | 25.44 |
CochLear (CHEOY) | Australia | $12.739B | 0.00 |
Solventum (SOLV) | United States | $12.214B | 0.00 |
Medpace Holdings (MEDP) | United States | $11.215B | 31.59 |
Charles River Laboratories (CRL) | United States | $11.042B | 21.34 |
Doximity (DOCS) | United States | $10.778B | 63.79 |
HealthEquity (HQY) | United States | $8.750B | 47.49 |
Sonic Healthcare (SKHHY) | Australia | $8.450B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $6.881B | 32.03 |
Life Times (LTH) | United States | $5.005B | 33.12 |
Sotera Health (SHC) | United States | $4.402B | 23.55 |
Organon (OGN) | United States | $4.012B | 4.05 |
Surgery Partners (SGRY) | United States | $3.759B | 42.85 |
BrightSpring Health Services (BTSG) | United States | $3.402B | 72.37 |
PACS (PACS) | United States | $3.129B | 0.00 |
Concentras Parent (CON) | United States | $2.579B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.523B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.446B | 0.00 |
Premier (PINC) | United States | $2.301B | 11.48 |
GeneDx Holdings (WGS) | United States | $2.113B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.783B | 47.00 |
Teladoc Health (TDOC) | United States | $1.670B | 0.00 |
Progyny (PGNY) | United States | $1.551B | 29.62 |
Pediatrix Medical (MD) | United States | $1.331B | 13.02 |
CareDx (CDNA) | United States | $1.251B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
AMN Healthcare Services Inc (AMN) | United States | $0.993B | 6.72 |
Embecta (EMBC) | United States | $0.898B | 5.99 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
InnovAge Holding (INNV) | United States | $0.778B | 0.00 |
Agilon Health (AGL) | United States | $0.770B | 0.00 |
SBC Medicals (SBC) | United States | $0.717B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.510B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.442B | 0.00 |
DocGo (DCGO) | United States | $0.426B | 16.00 |
Enhabit (EHAB) | United States | $0.383B | 33.09 |
COMPASS Pathways (CMPS) | United Kingdom | $0.346B | 0.00 |
LifeMD (LFMD) | United States | $0.310B | 0.00 |
ModivCare (MODV) | United States | $0.244B | 13.24 |
Sera Prognostics (SERA) | United States | $0.242B | 0.00 |
Beauty Health (SKIN) | United States | $0.211B | 0.00 |
Nutex Health (NUTX) | United States | $0.204B | 0.00 |
Biodesix (BDSX) | United States | $0.204B | 0.00 |
MultiPlan (MPLN) | United States | $0.141B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.120B | 0.00 |
So-Young (SY) | China | $0.073B | 17.77 |
Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
OncoCyte (OCX) | United States | $0.051B | 0.00 |
NeueHealth (NEUE) | United States | $0.042B | 1.12 |
Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.027B | 0.00 |
Oncology Institute (TOI) | United States | $0.022B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
XWELL (XWEL) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
KindlyMD (KDLY) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |